Details for 2016763585

Up to date per 01.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE KOMBINATIONEN MIT (A) INHIBITOR LEE011 (=RIBOCICLIB) DER CYCLIN-ABHÄNGIGEN KINASE 4/6 (CDK4/6) UND (B) INHIBITOR ERLOTINIB DES EPIDERMALEN WACHSTUMSFAKTORREZEPTOR (EGFR) ZUR BEHANDLUNG ODER VORBEUGUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016763585

EP Publication Number

3340990

E-Number

1183145

Language

PCT Number

IB16055044

Publication Date

04.07.2018 A

25.09.2019 B1

Registration Date

25.09.2019

AT Publication Date

15.10.2019

Application Date

24.08.2016

Registration Number

Priorities

28.08.2015

201562211031 P

IPC

A61K 31/517 20060101AFI20170322BHEP

Maximum Duration of Protection

24.08.2036

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

CAPONIGRO, Giordanoc/o Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

HORN-SPIROHN, Thomasc/o Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

LEHAR, Josephc/o Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US